Global Leukaemia, Lymphoma and Biosimilars Medical Director (non-MD) (Secondment - 6 Months)

Why Patients Need You

The Global Leukaemia, Lymphoma and Biosimilars Medical Director will be an integral member of the Haematology Cancer Global Medical Affairs Team. The Director combines the medical expertise and understanding of the patients’ and physicians’ point of view with that of the product/therapeutic area and is a part of a working environment where colleagues always understand and exhibit customer-focused medical professionalism with honor and integrity.

What You Will Achieve

The Global Leukaemia, Lymphoma and Biosimilars Medical Director will partner cross-functionally with Value & Evidence, Clinical Development, Legal, Compliance and Commercial colleagues to develop medical strategy and partner as appropriate to execute activities. 

How You Will Achieve It

• Collaborate with a broad range of stakeholders to understand unmet medical needs and the therapeutic environment including the HCP and patient perspective, regulatory and access dynamics across regions and, integrate needs and insights to inform on-going Global Medical Strategy.

• Facilitate scientific engagement across a broad range of stakeholders to gain insight and increase understanding of the unmet need and treatment landscape in malignant haematology.

• Gather medical insights and translate them into actionable strategies focused on patients’ needs.

• Contribute to strategic evidence generation and dissemination plans.

• Support the execution of evidence generation activities including independent research, clinical and research collaborations, and Pfizer non-interventional and interventional studies including post-hoc data generation.

• Work on internal data interpretation and alignment activities.

• Support evidence dissemination and education activities including scientific publications and scientific exchange.

• Participate in and contribute to medical strategy governance teams.

• Develop/refine asset scientific narratives.

Qualifications

Must-Have

• BA/BS with 8+ years of experience in relevant area of clinical/biological sciences.

• A minimum of three years of Medical Affairs experience.

• Proven track record of ability to work successfully with cross-functional colleagues in a matrix team setting across countries and internationally with diverse colleagues.

• Well organized with the ability to prioritize and manage multiple demands while working independently.

• Very strong communication, interpersonal and relationship building capacity with demonstrated emotional intelligence and change agility.

• Strong strategic thinking and decision-making skills with the ability to translate country and regional insights and therapeutic area understanding into medical plans and strategies.

• Ability to assimilate large amount of complex data from diverse sources to convey complex concepts to non-scientific colleagues.

• Ability to influence without authority.

• Fluency in written and spoken English.

Nice-to-Have

• MBA/MD with 7+ years of experience; OR PhD with 5+ years of experience.

• Clinical and disease knowledge base in malignant Haematology strongly preferred.

• International experience a plus.

• Global experience a plus.

• Regulatory and/or clinical development experience a plus.

  
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
 

Other Job Details

• Last Date to Apply for Job: October 1, 2025

• Additional Location Information: United States - Any Pfizer Site, Europe - Any Pfizer Site

• Eligible for Relocation Package – NO

• Secondment 6 months

• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.

• There will be no change to your current work location.

• Position is considered Flexible, and colleagues are expected to comply with Log In For Your Day (LIFYD) requirements at site location (e.g. about 2.5 days a week in office).